131 related articles for article (PubMed ID: 12630986)
1. Genotyping of four genetic polymorphisms in the CYP1A2 gene in the Egyptian population.
Hamdy SI; Hiratsuka M; Narahara K; Endo N; El-Enany M; Moursi N; Ahmed MS; Mizugaki M
Br J Clin Pharmacol; 2003 Mar; 55(3):321-4. PubMed ID: 12630986
[TBL] [Abstract][Full Text] [Related]
2. Frequencies of four genetic polymorphisms in the CYP1A2 gene in Turkish population.
Bilgen T; Tosun O; Luleci G; Keser I
Genetika; 2008 Aug; 44(8):1133-6. PubMed ID: 18825963
[TBL] [Abstract][Full Text] [Related]
3. Genetic polymorphisms of the CYP3A4, CYP3A5, CYP3A7 and CYP1A2 among the Jordanian population.
Salameh G; Al Hadidi K; El Khateeb M
Environ Toxicol Pharmacol; 2012 Jul; 34(1):23-33. PubMed ID: 22426036
[TBL] [Abstract][Full Text] [Related]
4. Polymorphisms in the cytochrome P450 CYP1A2 gene (CYP1A2) in colorectal cancer patients and controls: allele frequencies, linkage disequilibrium and influence on caffeine metabolism.
Sachse C; Bhambra U; Smith G; Lightfoot TJ; Barrett JH; Scollay J; Garner RC; Boobis AR; Wolf CR; Gooderham NJ;
Br J Clin Pharmacol; 2003 Jan; 55(1):68-76. PubMed ID: 12534642
[TBL] [Abstract][Full Text] [Related]
5. Genotype and allele frequencies of TPMT, NAT2, GST, SULT1A1 and MDR-1 in the Egyptian population.
Hamdy SI; Hiratsuka M; Narahara K; Endo N; El-Enany M; Moursi N; Ahmed MS; Mizugaki M
Br J Clin Pharmacol; 2003 Jun; 55(6):560-9. PubMed ID: 12814450
[TBL] [Abstract][Full Text] [Related]
6. Inducibility of CYP1A2 by omeprazole in vivo related to the genetic polymorphism of CYP1A2.
Han XM; Ouyang DS; Chen XP; Shu Y; Jiang CH; Tan ZR; Zhou HH
Br J Clin Pharmacol; 2002 Nov; 54(5):540-3. PubMed ID: 12445035
[TBL] [Abstract][Full Text] [Related]
7. Functional allele and genotype frequencies of CYP1A2, CYP2B6 and iNOS among mainland Chinese Tibetan, Mongolian, Uygur and Han populations.
Qi GZ; Zhang ZY; Wang X; Yin SJ; Lou YQ; Zhang GL
J Clin Pharm Ther; 2016 Feb; 41(1):84-91. PubMed ID: 26763760
[TBL] [Abstract][Full Text] [Related]
8. The cytochrome P450 CYP1A2 genetic polymorphisms *1F and *1D do not affect clozapine clearance in a group of schizophrenic patients.
Kootstra-Ros JE; Smallegoor W; van der Weide J
Ann Clin Biochem; 2005 May; 42(Pt 3):216-9. PubMed ID: 15949157
[TBL] [Abstract][Full Text] [Related]
9. Detection of three genetic polymorphisms in the 5'-flanking region and intron 1 of human CYP1A2 in the Japanese population.
Chida M; Yokoi T; Fukui T; Kinoshita M; Yokota J; Kamataki T
Jpn J Cancer Res; 1999 Sep; 90(9):899-902. PubMed ID: 10551315
[TBL] [Abstract][Full Text] [Related]
10. Rapid genotyping for relevant CYP1A2 alleles by pyrosequencing.
Skarke C; Kirchhof A; Geisslinger G; Lötsch J
Eur J Clin Pharmacol; 2005 Dec; 61(12):887-92. PubMed ID: 16307269
[TBL] [Abstract][Full Text] [Related]
11. The effect of the CYP1A2 *1F mutation on CYP1A2 inducibility in pregnant women.
Nordmark A; Lundgren S; Ask B; Granath F; Rane A
Br J Clin Pharmacol; 2002 Nov; 54(5):504-10. PubMed ID: 12445029
[TBL] [Abstract][Full Text] [Related]
12. CYP1A2*1D and *1F polymorphisms have a significant impact on olanzapine serum concentrations.
Czerwensky F; Leucht S; Steimer W
Ther Drug Monit; 2015 Apr; 37(2):152-60. PubMed ID: 25090458
[TBL] [Abstract][Full Text] [Related]
13. The G-113A polymorphism in CYP1A2 affects the caffeine metabolic ratio in a Chinese population.
Chen X; Wang L; Zhi L; Zhou G; Wang H; Zhang X; Hao B; Zhu Y; Cheng Z; He F
Clin Pharmacol Ther; 2005 Sep; 78(3):249-59. PubMed ID: 16153396
[TBL] [Abstract][Full Text] [Related]
14. Comparisons of CYP1A2 genetic polymorphisms, enzyme activity and the genotype-phenotype relationship in Swedes and Koreans.
Ghotbi R; Christensen M; Roh HK; Ingelman-Sundberg M; Aklillu E; Bertilsson L
Eur J Clin Pharmacol; 2007 Jun; 63(6):537-46. PubMed ID: 17370067
[TBL] [Abstract][Full Text] [Related]
15. Single nucleotide polymorphisms and haplotypes of CYP1A2 in a Japanese population.
Soyama A; Saito Y; Hanioka N; Maekawa K; Komamura K; Kamakura S; Kitakaze M; Tomoike H; Ueno K; Goto Y; Kimura H; Katoh M; Sugai K; Saitoh O; Kawai M; Ohnuma T; Ohtsuki T; Suzuki C; Minami N; Kamatani N; Ozawa S; Sawada J
Drug Metab Pharmacokinet; 2005 Feb; 20(1):24-33. PubMed ID: 15770072
[TBL] [Abstract][Full Text] [Related]
16. Determination of -3858G-->A and -164C-->A genetic polymorphisms of CYP1A2 in blood and saliva by rapid allelic discrimination: large difference in the prevalence of the -3858G-->A mutation between Caucasians and Asians.
Todesco L; Török M; Krähenbühl S; Wenk M
Eur J Clin Pharmacol; 2003 Aug; 59(4):343-6. PubMed ID: 12851801
[TBL] [Abstract][Full Text] [Related]
17. Development of a high throughput single nucleotide polymorphism screening method for the cytochrome P450 1A2 polymorphisms CYP1A2*1C and CYP1A2*1F: are they useful as predictive markers in mental disorders?
Klemm M; Eidens M; Lorenz M; Prause S; Weise A; Dahmen N; Forst T; Pfützner A
Clin Lab; 2010; 56(9-10):473-80. PubMed ID: 21086794
[TBL] [Abstract][Full Text] [Related]
18. Quercetin significantly inhibits the metabolism of caffeine, a substrate of cytochrome P450 1A2 unrelated to CYP1A2*1C (-2964G>A) and *1F (734C>A) gene polymorphisms.
Xiao J; Huang WH; Peng JB; Tan ZR; Ou-Yang DS; Hu DL; Zhang W; Chen Y
Biomed Res Int; 2014; 2014():405071. PubMed ID: 25025048
[TBL] [Abstract][Full Text] [Related]
19. Genotype and allele frequencies of polymorphic cytochromes P450 CYP1A2 and CYP2E1 in Mexicans.
Mendoza-Cantú A; Castorena-Torres F; Bermudez M; Martínez-Hernández R; Ortega A; Salinas JE; Albores A
Cell Biochem Funct; 2004; 22(1):29-34. PubMed ID: 14695651
[TBL] [Abstract][Full Text] [Related]
20. G-2964A and C734A genetic polymorphisms of CYP1A2 in Chinese population.
Han XM; Chen XP; Wu QN; Jiang CH; Zhou HH
Acta Pharmacol Sin; 2000 Nov; 21(11):1031-4. PubMed ID: 11501059
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
